Influence of sCD40L on gastric cancer cell lines

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5459-5464

  Li, Rui ^a   Chen, Wei Chang ^a   Pang, Xue Qin ^a   Tian, Wen Yan ^a   Zhang, Xue Guang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

AGS; Apoptosis; BGC 823; Cell cycle; Gastric cancer; sCD40L

Indexed keywords

CD40 LIGAND; SOLUBLE CD40 LIGAND; TETRAZOLIUM BLUE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; STOMACH CANCER;

APOPTOSIS; BIOLOGICAL ASSAY; CD40 LIGAND; CELL CYCLE; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; HUMANS; SOLUBILITY; STOMACH NEOPLASMS;

EID: 84855228942     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0702-9     Document Type: Article

References (31)

1. Kizaki H, Ohnishi Y, Mizuno Y, Azuma Y, Mizuno Y, Ohsaka F (1992) Arabinolcytosine and 5'-azacytisine induce internucleos-omal DNA fragmentation and cell death in thymocytes. Immu-nopharmacology 24:219-227 (Pubitemid 23003858)
2. Askew DS, Ashmun RA, Simmons BC, Cleveland JL (1991) Constitutive c-myc expression in an IL-3 dependent myeloid ce ll line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922 (Pubitemid 21924028)
3. Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri VAM, Bavazzano A, Comolli R, Paoletti F, La Porta CAM (2004) Increased plasma levels of soluble CD40, together with the decrease of TGFb1, as possible differential markers of Alzheimer disease. Exp Gerontol 39:1555-1561 (Pubitemid 39410556)
4. Calingasan NY, Erdely HA, Altar CA (2002) Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol Aging 23:31-39 (Pubitemid 34066533)
5. Futagami S, Hiratsuka T, Suzuki K, Tatsuguchi A, Kusunoki M, Shinji Y, Shinoki K, Gudis K, Nishigaki H, Wada K, Miyake K, Tsukui T, Sakamoto C (2003) COX-2 and VEGF expression in endothelial cells through their interaction with CD40-CD40 ligand in Helicobacter pylori infection. Gastroenterology 124: A403-A404
6. Zhang L, Huang H, Wu K, Wang M, Wu B (2010) Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep 37(6):2579-2586
7. Hou R, Cao B, Chen Z, Li Y, Ning T, Li C, Xu C, Chen Z (2010) Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep 37(1):515-520
8. Ruybal P, José Gravisaco M, Barcala V, Escalada A, Di Sciullo P, Waldner C, Mongini C (2008) Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40. Vaccine 26:697-705
9. Eeva J, Ropponen A, Nuutinen U, Eeva S-T, Mättö M, Eray M, Pelkonen J (2007) The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP. Mol Immunol 44:1230-1237 (Pubitemid 44415970)
10. Shi L, Zhao M, Luo Q, Ma YM, Zhong JL, Yuan XH, Huang CZ (2010) Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells. Mol Biol Rep 37(5):2189-2198
11. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135 (Pubitemid 28183361)
12. Tong AW, Stone MJ (2003) Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Ther 10:1-13 (Pubitemid 36222071)
13. Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopo-ulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC (1999) Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 93:2999-3007 (Pubitemid 29200792)
14. Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL, Murphy WJ, James K, Taub DD (2000) Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol 37:515-526 (Pubitemid 32001693)
15. Xu J, Gao DF, Yan GL, Fan JM (2009) Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells. Mol Biol Rep 36(6):1559-1564
16. Hodgkin PD, Yamashita LC, Seymour B, Coffman RL, Kehry MR (1991) Membranes from both Th1 and Th2 T-cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig. J Immunol 147(11):3696-3702
17. Grewal IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378(6557):617-620
18. DeKruyff RH, Gieni RS, Umetsu DT (1997) Antigen-driven but not lipopolysaccharide driven IL-12 production in macrophages requires triggering of CD40. J Immunol 158(1):359-366 (Pubitemid 127483877)
19. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E (1996) High level IL-12 production by murine dendritic cells: upregulation viaMHCclass II andCD40 molecules and downreg-ulation by IL-4 and IL-10. J Exp Med 184(2):741-746 (Pubitemid 26324128)
20. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanza-vecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T-cell stimulatory capacity: T-T help via APC activation. J Exp Med 184(2):747-752 (Pubitemid 26324129)
21. Wingett DG, Vestal RE, Forcier K, Hadjokas N (1998) Nielson CP: CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis. Breast Cancer Res Treat 50:27-36 (Pubitemid 28438858)
22. Pedersen AE, Thorn M, Gad M, Walter MR, Johnsen HE, Ga-arsdal E, Nikolajsen K, Buus S, Claesson MH, Svane IM (2005) Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination. Scand J Immunol 61:147-156 (Pubitemid 40255358)
23. Pinzon-Charry A, Schmidt CW, López JA (2006) The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction. Breast Cancer Res 8:402
24. Masoudi M, Saadat I, Omidvari S, Saadat M (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36(4):781-784
25. Li R, Chen W-C, Wang W-P, Tian W-Y, Zhang X-G (2009) Optimization of extraction technology of Astragalus polysac-charides by response surface methodology and its effect on CD40. Carbohydr Polym 78:784-788
26. Li R, Chen W-C, Wang W-P, Tian W-Y, Zhang X-G (2009) Extraction, characterization of Astragalus polysaccharides and its immune modulating activities in rats with gastric cancer. Car-bohydr Polym 78:738-742
27. Li R, Chen W-C, Pang X-Q, Hua C, Li L, Zhang X-G (2009) Expression of CD40 and CD40L in gastric cancer tissue and its clinical significance. Int J Mol Sci 10:3900-3917
28. Li R, Chen W-C, Wang W-P, Tian W-Y, Zhang X-G (2010) CD40 signaling activated by agonistic anti-CD40 monoclonal antibody 5C11 has different effects on biological behavior of gastric carcinoma cells. Immunol Lett 131:120-125
29. Tolis C, Peters GJ, Ferreira CG, Pinedo HM, Giaccone G (1999) Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer 35:796-807 (Pubitemid 29258151)
30. Wang N, Dong XJ, Zhou RM, Guo W, Zhang XJ, Li Y (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36(2):357-364
31. Joo H-G, Fleming TP, Tanaka Y, Dunn TJ, Linehan DC, Goed-egebuure PS, Eberlein TJ (2002) Human dendritic cells induce tumor-specific apoptosis by soluble factors. Int J Cancer 102:20-28